(Atlanta, GA)— The American Partnership for Eosinophilic Disorders (APFED) will be hosting its 16th annual patient education conference on eosinophil-associated disease July 6-7 at the Hyatt Regency Aurora-Denver.
Eosinophil-associated diseases (EADs) are chronic inflammatory disorders characterized by elevated levels of eosinophils (a type of white blood cell) in one or more specific places in tissues, organs, and/or bloodstream, which in turn causes inflammation and damage. These chronic diseases require lifelong treatment and symptoms may be debilitating.
The 2018 Eos Connection conference is being held in collaboration with Children’s Hospital Colorado (Children’s Colorado) and the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). The program features more than 25 patient-tailored educational and experiential sessions for patients, caregivers, researchers, clinicians, advocates, industry representatives, and others. Attendees will learn the latest advancements in the diagnosis and treatment of EAD, research updates, and practical strategies to help patients with disease management. Those who cannot attend in-person may participate in/view a webcast of general sessions offered on both days.
“APFED is honored to collaborate with the Gastrointestinal Eosinophilic Diseases Program at Children’s Colorado as well as the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) for our annual event,” said APFED Executive Director Mary Jo Strobel. “The Eos Connection conference offers participants a valuable opportunity to exchange their own knowledge, experiences, needs, and perspectives.”
“APFED’s mission to passionately embrace, support, and improve the lives of patients and families affected by EGIDs aligns with my goal to strengthen the care and service we provide in our seven-state region,” said Glenn Furuta, MD, Director, Gastrointestinal Eosinophilic Diseases Program at Children’s Colorado. “I am proud to be part of a conference where families come year after year not only to learn the latest information and strategies for better living with EGIDs, but also to reconnect with one another and to welcome new members to our community.”
“It is important to me that families are provided the information and education they need to make informed decisions and choose the treatment option that best fits their goals,” said Dan Atkins, MD, Co-Director, Gastrointestinal Eosinophilic Diseases Program, Pediatric Allergy and Head of the Allergy and Immunology Section at Children’s Colorado. “APFED gives families the opportunity to share challenges, concerns, and coping strategies with others who truly understand provides patients and family members with a sense of relief and empowerment.”
Eos Connection 2018 is made possible thanks to the generous support of APFED’s Education Partners, including Presenting Partner Celgene, and Platinum Partners AstraZeneca and EleCare®. Learn more about the conference and register at apfed.org.
About American Partnership for Eosinophilic Disorders (APFED)
APFED is a non-profit organization dedicated to patients and their families coping with eosinophilic disorders. APFED’s mission is to passionately embrace, support, and improve the lives of patients and families affected by eosinophil-associated diseases through education and awareness, research, support, and advocacy. www.apfed.org
About Children’s Hospital Colorado
Children’s Hospital Colorado is a leading pediatric network 100 percent dedicated to the health and well-being of children, adolescents and young adults. Consistently acknowledged as one of the nation’s top pediatric hospitals by U.S. News & World Report, Children’s Colorado is recognized nationally and internationally for its medical, research, education and advocacy programs. It is at the forefront of research in childhood disease and pioneering treatments that are shaping the future of pediatrics, as well as offering everyday care for kids throughout Colorado and surrounding states. Founded in 1908, Children’s Colorado offers a full spectrum of family-centered care at its urgent, emergency and specialty care locations throughout Metro Denver and Southern Colorado, including its location on the Anschutz Medical Campus. Scheduled to open in early 2019, the new Children’s Hospital Colorado, Colorado Springs will be the first pediatric-only hospital in southern Colorado. For more information, visit www.childrenscolorado.org, or connect with us on Facebook and Twitter.
Children’s Hospital Colorado complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex.
ATENCIÓN: si habla español, tiene a su disposición servicios gratuitos de asistencia lingüística. Llame al 1-720-777-9800.
CHÚ Ý: Nếu bạn nói Tiếng Việt, có các dịch vụ hỗ trợ ngôn ngữ miễn phí dành cho bạn. Gọi số 1-720-777-9800 http://www.hhs.gov/civil-rights/for-individuals/section-1557
About the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)
CEGIR (U54AI117804) is a part of the NCATS Rare Diseases Clinical Research Network (RDCRN). RDCRN is an initiative of the Office of Rare Diseases Research (ORDR), NCATS, funded through a collaboration between the NCATS, the NIAID and the NIDDK. CEGIR is also supported by patient advocacy groups including APFED, CURED and EFC. www.rdcrn.org/cegir.